These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1313173)

  • 21. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport of the antiviral nucleoside analogs 3'-azido-3'-deoxythymidine and 2',3'-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes.
    Yao SY; Cass CE; Young JD
    Mol Pharmacol; 1996 Aug; 50(2):388-93. PubMed ID: 8700147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to AZT and ddC during long-term combination therapy in patients with advanced infection with human immunodeficiency virus.
    Richman DD; Meng TC; Spector SA; Fischl MA; Resnick L; Lai S
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):135-8. PubMed ID: 7905522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
    Pizzo PA; Butler K; Balis F; Brouwers E; Hawkins M; Eddy J; Einloth M; Falloon J; Husson R; Jarosinski P
    J Pediatr; 1990 Nov; 117(5):799-808. PubMed ID: 2172501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of 2',3'-dideoxycytidine: an inhibitor of human immunodeficiency virus.
    Broder S
    Am J Med; 1990 May; 88(5B):2S-7S. PubMed ID: 1692446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus.
    Zhou XJ; Squires K; Pan-Zhou XR; Bernhard S; Agrofoglio L; Kirk M; Duchin KL; Sommadossi JP
    J Clin Pharmacol; 1997 Mar; 37(3):201-13. PubMed ID: 9089422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC.
    Viora M; Di Genova G; Quaranta MG; Boirivant M; Camponeschi B
    J Clin Immunol; 1998 Sep; 18(5):346-54. PubMed ID: 9793827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.
    Van Draanen NA; Tisdale M; Parry NR; Jansen R; Dornsife RE; Tuttle JV; Averett DR; Koszalka GW
    Antimicrob Agents Chemother; 1994 Apr; 38(4):868-71. PubMed ID: 7518218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells.
    Benbrik E; Chariot P; Bonavaud S; Ammi-Saïd M; Frisdal E; Rey C; Gherardi R; Barlovatz-Meimon G
    J Neurol Sci; 1997 Jul; 149(1):19-25. PubMed ID: 9168161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of dinucleoside methylphosphonates of 3'-azido-3'-deoxythymidine and 2', 3'-dideoxycytidine.
    Puech F; Gosselin G; Balzarini J; Good SS; Rideout JL; De Clercq E; Imbach JL
    Antiviral Res; 1990 Jul; 14(1):11-23. PubMed ID: 1964371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of 2',3'-dideoxycytidine in rats: application to interspecies scale-up.
    Ibrahim SS; Boudinot FD
    J Pharm Pharmacol; 1989 Dec; 41(12):829-34. PubMed ID: 2576444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro.
    Gosselin G; Schinazi RF; Sommadossi JP; Mathé C; Bergogne MC; Aubertin AM; Kirn A; Imbach JL
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1292-7. PubMed ID: 8092827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3'-Azido-2',3'-dideoxyuridine (AzddU): comparative pharmacokinetics with 3'-azido-3'-deoxythymidine (AZT) in monkeys.
    Boudinot FD; Schinazi RF; Gallo JM; McClure HM; Anderson DC; Doshi KJ; Kambhampathi PC; Chu CK
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):219-28. PubMed ID: 2328158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine.
    Chu CK; Bhadti VS; Doshi KJ; Etse JT; Gallo JM; Boudinot FD; Schinazi RF
    J Med Chem; 1990 Aug; 33(8):2188-92. PubMed ID: 2374145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism and rate of placental transfer of zalcitabine (2',3'-dideoxycytidine) in Macaca nemestrina.
    Tuntland T; Nosbisch C; Baughman WL; Massarella J; Unadkat JD
    Am J Obstet Gynecol; 1996 Mar; 174(3):856-63. PubMed ID: 8633656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
    J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of azidothymidine and its major metabolite glucuronylazidothymidine in hemophiliacs coinfected with human immunodeficiency virus and chronic hepatitis C.
    Rockstroh JK; Reichel C; Hille H; Oldenburg J; Brackmann HH
    Am J Ther; 1998 Nov; 5(6):387-91. PubMed ID: 10099082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
    Skowron G; Merigan TC
    Am J Med; 1990 May; 88(5B):20S-23S. PubMed ID: 2159705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys.
    Cretton EM; Schinazi RF; McClure HM; Anderson DC; Sommadossi JP
    Antimicrob Agents Chemother; 1991 May; 35(5):801-7. PubMed ID: 1854160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.